Fenoprofen

This classification denotes a cyclooxygenase inhibitor with the molecular formula C15H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RA33EAC7KY, chemically known as hydratropic acid, m-phenoxy-, (+-)- but generally known as fenoprofen, which bears US NIH Compound Identifier 3342. European Medicines Agency schedules Fenoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07578MIG. The term FENOPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules fenoprofen in its Anatomical Therapeutic Chemical (ATC) Classification. FENOPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenoprofen under HS 29189900 and SITC 51396. As of Q4 2014, FENOPROFEN remains the US FDA Preferred Term for this commodity. Fenoprofen bears US NLM identifiers UMLS ID C0015837 and NCI Concept Code C61760. SMILES: O(C1CC(C(C)C(=O)O)CCC1)C1CCCCC1.